Leishmaniasis
Issue Description
Canine Leishmania is a zoonotic disease most commonly caused by the bite of an infected Phlebotomus sandfly. Canine Leishmaniasis was first identified in Europe
in 1903 and in 1940 it was determined that 40% of all dogs in Rome were positive for Leishmaniasis. Traditionally thought of as a disease only found near the
Mediterrean basin, 2008 research claims new findings are evidence that canine leishmaniasis is currently expanding in continental climate areas of northwestern
Italy, far from the recognized disease-endemic areas along the Mediterranean coasts. Cases of Leishmaniasis began appearing in North America in 2000, Leishmania
positive Foxhounds have been reported in 22 states and 2 provinces of Canada as of 2008.
Symptoms
Cutaneous
Skin Lesions
Alopecia
Ulcerative or Exfoliative dermatitis
Visceral
Swollen Lymphnodes
Ocular signs
Progressive loss of weight with decreased appetite
Epistaxis (nose bleeds)
Kidney failure - increased urination and drinking
Diagnostics
In the United States certain breed clubs are strongly recommending screening for Leishmania especially in imported breeding stock from endemic locations. For
reasons yet unidentified The Foxhound and Neapolitan Mastiff seem to be predisposed or at higher risk for disease. The Italian Spinone Club of America is also
requesting that all breeders and owners submit samples for testing, the club reports that 150 Spinone Italiano have tested positive in the United States.
In the United States the following veterinary colleges & government bodies assist with testing and treatment of Leishmania positive dogs:
Iowa State University Dept of Pathology
North Carolina Center for Disease Control
The PCR method for the detection of Leishmania DNA is the most sensitive and accurate method for detecting Leishmania. A study completed on Foxhounds whom were
tested with PCR showed approximately 20% of the tested dogs positive, the same population tested with anti-body serology (the traditional testing method in the US)
showed only 5% positive.
Diagnosis can be complicated by false positives caused by the Lepto vaccine and false negatives caused by testing methods which
lack sufficient sensitivity.
Treatment
Currently there exist no cure for Canine Leishmaniasis, there are various treatment options available in different countries. In the United States all drugs used to
treat Canine Leishmaniasis are controlled and regulated by the Center for Disease Control (CDC). Treatment is best coordinated with veterinarian research hospitals
and the CDC. Treatment does vary by geographic area, strain of infection and exhibited symptoms. Dogs can be asymptomatic for years.
Most common treatments include:
L.infantum
Pentavalent antimonials
Meglumine antimoniate
Amphotericin B
L. Donovani
Antimonial resistant
Polyene antibiotic amphotericin B
Given the recent appearance of L.infantum in the United States and the absence of a known vector the CDC recommends euthanasia of infected dogs due to their
concerns of spreading the disease and its zoonotic nature. To date no known cases of dog to human transmission have occurred in the United States.
Prevention & Vaccines
In areas where the known vector is a sandfly an deltamethrin collars worn by the dog has been proven to be 86% effective. The sandfly is most active at dusk and
dawn, keeping your dog indoors during those peak times will help minimize exposure.
Unfortunatley, there is no one answer for Leishmania prevention nor
will one vaccine cover multiple species. Different virulence factors have been identified for distinct Leishmania species, and there are profound differences in
the immune mechanisms that mediate susceptibility/resistance to infection and in the pathology associated with disease.
In 2003 Fort Dodge released the
Leshmune Vaccine in Brazil for L.donovani. Studies indicated up to 87% protection. Most common side effects from the vaccine have been noted as anorexia and local
swelling. The president of the Brazil Regional Council of Veterinary Medicine, Marcia Villa warns that since vaccinated dogs develop antibodies they can be difficult
to distinguish vaccinated dogs from asymptomatic infected dogs. Studies are also indicating that the Leshmune vaccine may be reliable in treating L. Chagasi and a
possible treatment for already infected dogs with L.donovani.
The material and information on this website, including any merchandise, information or service provided through this website, is provided "as is"
with all faults and without warranty of any kind from the Furry Critter Network, expressed or implied. In no event shall the Furry Critter Network be
liable for any direct damages, special, incidental or consequential damages, lost profits, or any indirect damages arising from the use or inability
to use this website, even if the Furry Critter Network has been informed of the possibility thereof.